Journal of Neurology

Article	Citations
Prevalence of infratentorial superficial siderosis in a large general population sample from the UK Biobank	122
A role for the Epstein–Barr virus in multiple sclerosis aetiology?	117
The deltoid muscle and the pattern of paresis in ALS	117
Pallidal deep brain stimulation for patients with myoclonus-dystonia without SGCE mutations	108
Richard Caton (1842-1926)	102
CSF biomarkers of B-cell activation in multiple sclerosis: a clinical perspective	99
Microstructural characterization of multiple sclerosis lesion phenotypes using multiparametric longitudinal analysis	94
Neuromyelitis optica spectrum disorder with a familial Mediterranean fever gene E84K mutation	89
Tacrolimus-induced Parkinsonism	88
Interpretable deep learning survival predictions in sporadic Creutzfeldt–Jakob disease	83
Different patterns of acute saccadic response to levodopa in de novo Parkinson’s disease	71
Reversible cerebral vasoconstriction syndrome after intravenous iron substitution: a case report	65
Brain 18F-FDG PET findings and sequential vestibular testing in SCA27B: a case report	63
Neurological manifestation of HEV infection: still a rare disease entity?	63
Halting progressive multifocal leukoencephalopathy with pembrolizumab: the case of a patient with multiple sclerosis under fingolimod	61
The DeMyers: Marian (1922–2012) and William (1924–2008)	61
Risk of secondary progression in patients with highly active multiple sclerosis treated with natalizumab: a real-life study	60
Hashimoto’s encephalopathy with diffuse leukoencephalopathy: serial MRI and gait analysis	59
Tourette syndrome: effects of acetyl-leucine in two individuals	58
Natalizumab-induced pneumonitis	57
Response to SARS-CoV-2 vaccination in multiple sclerosis patients on disease modifying therapies	57
Stroke frequency, associated factors, and clinical features in primary systemic vasculitis: a multicentric observational study	56
Correction to: Synergistic effects of vagus nerve stimulation and antiseizure medication	55
Correction to: Epilepsy related multimorbidity, polypharmacy and risks in adults with intellectual disabilities: a national study	55
Long-term outcome after decompressive hemicraniectomy for malignant middle cerebral artery infarction	55

Humoral response after accelerated schedule of HBV vaccination in MS patients before anti-CD20 therapy	54
A decision aid is not the quick fix for improving shared decision-making in advanced Parkinson’s disease: results of a mixed methods feasibility study	53
Exploring epigenetic modifications as potential biomarkers and therapeutic targets in amyotrophic lateral sclerosis	51
Increased aneurysm wall permeability colocalized with low wall shear stress in unruptured saccular intracranial aneurysm	49
Does visuospatial motion perception correlate with coexisting movement disorders in Parkinson’s disease?	49
Dystonia management across Europe within ERN-RND: current state and future challenges	48
International survey on the implementation of the European and American guidelines on disorders of consciousness	48
Acute symptomatic seizures and hippocampal sclerosis: the major contributor for post-stroke epilepsy?	48
A retrospective study of autoimmune cerebellar ataxia over a 20-year period in a single institution	48
Keeping an eye on Parkinson’s disease: color vision and outer retinal thickness as simple and non-invasive biomarkers	47
Phenotype-driven reanalysis reveals five novel pathogenic variants in 40 exome-negative families with Charcot–Marie–Tooth Disease	47
Eye tracking identifies biomarkers in α-synucleinopathies versus progressive supranuclear palsy	45
Improving conscientiousness through a smartphone app and telecoaching intervention: insights from multiple sclerosis and healthy aging samples	45
Longitudinal predictors of health-related quality of life in isolated dystonia	45
Analysis of C9orf72 repeat length in progressive supranuclear palsy, corticobasal syndrome, corticobasal degeneration, and atypical parkinsonism	44
Assessment of cognitive function, structural brain changes and fatigue 6 months after treatment of neuroborreliosis	44
Restless legs syndrome in Parkinson’s disease: epidemiology, pathogenetic overlaps, and clinical management	44
Tau levels in platelets isolated from Huntington’s disease patients serve as a biomarker of disease severity	43
A real-world study on the utility of regular rituximab treatment for neuromyelitis optica spectrum disorder	42
Dopaminergic responsiveness and dopaminergic challenge tests of Parkinson’s disease: a systematic review and meta-analysis	41
Genetic forms of tauopathies: inherited causes and implications of Alzheimer’s disease-like TAU pathology in primary and secondary tauopathies	41
Complications of reversible cerebral vasoconstriction syndrome in relation to age	41
Sensory neuropathy due to RFC1 in a patient with ALS: more than a coincidence?	40
Dizziness and spatial disorientation in patients with transient global amnesia: clinical and vestibular correlates	39
Neural correlates of dual-task walking in people with central neurological disorders: a systematic review	38
Recent applications of quantitative electroencephalography in adult intensive care units: a comprehensive review	38
Epileptic disorders in Becker and Duchenne muscular dystrophies: a systematic review and meta-analysis	38
SARA captures disparate progression and responsiveness in spinocerebellar ataxias	38
TS-HDS autoantibody: clinical characterization and utility from real-world tertiary care center experience	38
Prevalence of hereditary transthyretin amyloidosis in CIDP patients with red flags: a multicenter genetic screening and misdiagnosis analysis	38
Incidence of Guillain–Barré syndrome in Cuba before and during the Oropouche virus emergency, 2018–2024	37
Historical and current issues in HIV encephalitis, and the role of neuropathology in HIV disease: a pathological perspective	36
Long-term efficacy and safety of ravulizumab in adults with anti-acetylcholine receptor antibody-positive generalized myasthenia gravis: results from the phase 3 CHAMPION MG open-label extension	35
Explaining recovery from coma with multimodal neuroimaging	35
Brain network topology and future development of freezing of gait in Parkinson’s disease: a longitudinal study	35
Primary progressive aphasia: six questions in search of an answer	35
eHealth tools to assess the neurological function for research, in absence of the neurologist: a systematic review, part II (hardware)	34
Impulse control and correlation to dopamine agonist serum concentrations in people with Parkinson's disease	34
Genetic modifiers of upper limb function in Duchenne muscular dystrophy	34
Audiovisual analysis of the diagnostic video polysomnography in patients with isolated REM sleep behavior disorder	34
Walter Russell Brain (1895–1966)	34
Endolymphatic space is age-dependent	34
Procedural and Clinical Outcome of Stroke after thrombectomy according to etiology: results from a nationwide registry	34
Health-related quality of life in Japanese patients with multiple sclerosis	33
Dysregulation of the molecular clock by blood-borne factors in Alzheimer’s disease patients	33
Encephalitis in HIV-infected adults in the antiretroviral therapy era	33
Challenges in multinational rare disease clinical studies during COVID-19: regulatory assessment of cipaglucosidase alfa plus miglustat in adults with late-onset Pompe disease	33
Is there a spinal tap responder in progressive supranuclear palsy? The first prospective study	33
Amyotrophic lateral sclerosis stratification: unveiling patterns with virome, inflammation, and metabolism molecules	32
Longitudinal analysis and treatment of neuropsychiatric symptoms in post-acute sequelae of COVID-19	31

Risdiplam improves subjective swallowing quality in non-ambulatory adult patients with 5q-spinal muscular atrophy despite advanced motor impairment	31
Effectiveness of rituximab vs. ocrelizumab for the treatment of primary progressive multiple sclerosis: a real-world observational study	30
The complex relationship between antibody titers and clinical outcome in botulinum toxin type A long-term treated patients with cervical dystonia	30
Present and future of the diagnostic work-up of multiple sclerosis: the imaging perspective	30
Evaluating 18F-Florzolotau tau PET for Alzheimer’s disease diagnosis with 18F-Flortaucipir as reference	30
Longitudinal qualitative assessment of meaningful symptoms and relevance of WATCH-PD digital measures for people with early Parkinson’s	30
Neurological update: structural and functional imaging in epilepsy surgery	29
Cost effectiveness of different treatment strategies with natalizumab for pregnant women with multiple sclerosis	29
Ultra-late response (> 24 weeks) to anti-CGRP monoclonal antibodies in migraine: a multicenter, prospective, observational study	29
Off-label-dosing of non-vitamin K-dependent oral antagonists in AF patients before and after stroke: results of the prospective multicenter Berlin Atrial Fibrillation Registry	29
Cavernomas: to treat or not to treat?	29
Anti-SOX1 antibody-associated acute hemorrhagic leukoencephalitis	29
Machine learning for adaptive deep brain stimulation in Parkinson’s disease: closing the loop	29
Sutton’s law applies to functional neurology	28
Frontotemporal neurofibrillary tangles and cerebrovascular lesions are associated with autism spectrum behaviors in late-life dementia	28
Cerebral infarctions following an increase in corticosteroids: an atypical case of reversible cerebral vasoconstriction syndrome	28
Quantification of saccadic fatigability and diagnostic efficacy for myasthenia gravis	27
Left- vs right-sided migraine: a scoping review	27
Characterisation of RT-QuIC negative cases from the UK National CJD Research and Surveillance programme	27
Long-term clinical outcomes in patients with CIS treated with interferon beta-1b: results from the 15-year follow up of the BENEFIT trial	27
Inflammatory neuropathy with evidence of anti-GQ1b antibodies in angioimmunoblastic T cell lymphoma (AITL): a case report	27
Translocator protein (TSPO)-PET as diagnostic and monitoring tool in COVID-19 related MRI-negative brainstem encephalitis: a case report	26
Aphasia as a stroke mimic in older adults: a diagnostic challenge	26
The topography of infratentorial lesions in depression and anxiety in multiple sclerosis	26
A novel prediction score determining individual clinical outcome 3 months after juvenile stroke (PREDICT-score)	26
Relapses during treatment with monoclonal antibodies targeting B-cells in NMOSD	26
The intersection of delirium and long-term cognition in older adults: the critical role of delirium prevention	26
Correction: Pharmacogenomics of clinical response to Natalizumab in multiple sclerosis: a genome-wide multi-centric association study	26
The role of language-related functional brain regions and white matter tracts in network plasticity of post-stroke aphasia	25
Patent foramen ovale diagnosis in young stroke patients: analysis of recurrence and mortality	25
Mismatch between clinically defined classification of ALS stage and the burden of cerebral pathology	25
Air pollution, greenspace exposure and risk of Parkinson's disease: a prospective study of 441,462 participants	25
Progression independent of relapse activity in relapsing multiple sclerosis: impact and relationship with secondary progression	25
Architecture and anatomy of executive processes: evidence from verbal fluency and Trail Making Test in 2009 stroke patients	25
Regional free-water diffusion is more strongly related to neuroinflammation than neurodegeneration	25
Detection of patent foramen ovale in patients with ischemic stroke on prospective ECG-gated cardiac CT compared to transthoracic echocardiography	25
Quantitative brainstem and spinal MRI in amyotrophic lateral sclerosis: implications for predicting noninvasive ventilation needs	25
Outcome predictors of post-COVID conditions in the European Academy of Neurology COVID-19 registry	25
Equity in neuromuscular research: a 20-year analysis of race, ethnicity, sex, and age representation	25
Anxiety and depression in Charcot-Marie-Tooth disease: data from the Italian CMT national registry	25
Regional distribution of polymorphisms associated to the disease-causing gene of spinocerebellar ataxia type 3	25
Episodic symptoms caused by neurovascular conflict of vagus nerve due to hemilateral anterior inferior cerebellar artery	25
Neurophysiological and behavioural correlates of ocrelizumab therapy on manual dexterity in patients with primary progressive multiple sclerosis	25
Genetic variation of low-to-medium-affinity Fc-gamma receptors in Guillain-Barré syndrome	24
Artificial intelligence in neurology: opportunities, challenges, and policy implications	24
Distributions and network changes of brain activity in the acute phase of anti-NMDAR encephalitis: a MEG study	24
Analyzing the relationship between specific brain structural changes and the diffusion tensor image analysis along the perivascular space index in idiopathic normal pressure hydrocephalus	24
Proposal of new diagnostic criteria for fatal familial insomnia	24
The clinical phenotype of psychiatric-onset prodromal dementia with Lewy bodies: a scoping review	24
The frequency of non-motor symptoms in SCA3 and their association with disease severity and lifestyle factors	24
A multi-domain lifestyle intervention in multiple sclerosis: a longitudinal observational study	24
Systematic review and evidence gap mapping of biomarkers associated with neurological manifestations in patients with COVID-19	24
Estimation of ataxia severity in children with ataxia-telangiectasia using ankle-worn sensors	24
Retreating migraine patients in the second year with monoclonal antibodies anti-CGRP pathway: the multicenter prospective cohort RE-DO study	23
Associations of sleep disorders with cerebrospinal fluid α-synuclein in prodromal and early Parkinson’s disease	23
Intake reminders are effective in enhancing adherence to direct oral anticoagulants in stroke patients: a randomised cross-over trial (MAAESTRO study)	23
Natural history of facioscapulohumeral muscular dystrophy evaluated by multiparametric quantitative MRI: a prospective cohort study	23
Effect of siponimod on lymphocyte subsets in active secondary progressive multiple sclerosis and clinical implications	23
The role of serum neurofilament light (sNfL) as a biomarker in multiple sclerosis: insights from a systematic review	23
Fluctuations in serum aquaporin-4 antibody titers: the clinical significance in neuromyelitis optica spectrum disorder	23
The correlation between 9-HPT and patient-reported measures of upper limb function in multiple sclerosis: a systematic review and meta-analysis	23
Impact of COVID-19 pandemic on frequency of clinical visits, performance of MRI studies, and therapeutic choices in a multiple sclerosis referral centre	23
MRI-guided focused ultrasound: new hope for drug-resistant neurological conditions	23
Novel biomarkers and neuroimaging techniques in Parkinson’s disease	23
Rate of change in upper and lower motor neuron burden is associated with survival in amyotrophic lateral sclerosis	23
Genetic risk factors of Alzheimer’s Disease disrupt resting-state functional connectivity in cognitively intact young individuals	23
Different approaches to test orientation of self in space: comparison of a 2D pen-and-paper test and a 3D real-world pointing task	22
Precision diagnosis and precision treatment for the genetic epilepsies	22
Distal hereditary motor neuronopathy as a new phenotype associated with variants in BAG3	22
Measurement of upper limb function in ALS: a structured review of current methods and future directions	22
Loss of brainstem white matter predicts onset and motor neuron symptoms in C9orf72 expansion carriers: a GENFI study	22
Parkinson’s disease with hyposmia and dysautonomia: does it represent a distinct subtype?	22
Early use of high-efficacy therapies in multiple sclerosis in the United States: benefits, barriers, and strategies for encouraging adoption	22
Measuring cognitive impairment and monitoring cognitive decline in Huntington’s disease: a comparison of assessment instruments	22
Rho GTPase-activating protein 10 (ARHGAP10/GRAF2) is a novel autoantibody target in patients with autoimmune encephalitis	22
Evaluation of drivers of treatment switch in relapsing multiple sclerosis: a study from the Italian MS Registry	22
Frida Kahlo could have had cauda equina syndrome: a case report	22
Modulation of spontaneous motor unit potentials by a new motor cortical magnetic stimulation method in amyotrophic lateral sclerosis	22
Measuring the functional impact of cognitive impairment in Huntington’s disease	22
Recurrence and long-term outcomes of Tolosa-Hunt syndrome	22

Beneficial effect of N-acetyl-DL-leucine on cognitive function, emotional well-being and QoL in a mentally healthy elderly person	22
The impact of the SARS-CoV-2-pandemic on patients with chronic inflammatory neuropathies: results from the German INHIBIT register	22
Correction: Metabolomic profile of cerebrospinal fluid from patients with diffuse gliomas	22
Unprescribed cannabinoids and multiple sclerosis: a multicenter, cross-sectional, epidemiological study in Lombardy, Italy	21
Diagnosing primary lateral sclerosis: a clinico-pathological study	21
The effects of dopaminergic medication and task load on trembling and akinetic freezing of gait in Parkinson’s disease	21
Muscle MRI as a biomarker of disease activity and progression in myotonic dystrophy type 1: a longitudinal study	21
Hypothalamic atrophy in CANVAS/RFC1	21
The value of magnetic resonance imaging of the optic nerve for the diagnosis of multiple sclerosis in patients with optic neuritis	21
Diagnostic accuracy and usability of the EMBalance decision support system for vestibular disorders in primary care: proof of concept randomised controlled study results	21
Usefulness of subcutaneous immunoglobulin therapy in the management of myasthenia gravis: a retrospective cohort study	21
Frequency and predictors of poststroke epilepsy after mechanical thrombectomy for large vessel occlusion stroke: results from a multicenter cohort study	21
Specific clinical and radiological characteristics of anti-NMDA receptor autoimmune encephalitis following herpes encephalitis	21
A new genetic cause of spastic ataxia: the p.Glu415Lys variant in TUBA4A	21
Photophobia in headache disorders: characteristics and potential mechanisms	21
Diagnostic accuracy and confounders of vagus nerve ultrasound in amyotrophic lateral sclerosis—a single-center case series and pooled individual patient data meta-analysis	21
Epileptogenicity of white matter lesions in cerebral small vessel disease: a systematic review and meta-analysis	21
Efficacy and safety of adjunctive perampanel treatment in pediatric patients with epilepsy aged 4–12 years: a real-world study	20
A perspective on persistent toxicants in veterans and amyotrophic lateral sclerosis: identifying exposures determining higher ALS risk	20
Impacts of medication non-adherence to major modifiable stroke-related diseases on stroke prevention and mortality: a meta-analysis	20
Quantitative whole-body muscle MRI in idiopathic inflammatory myopathies including polymyositis with mitochondrial pathology: indications for a disease spectrum	20
Motor and non-motor outcome in tremor dominant Parkinson’s disease after MR-guided focused ultrasound thalamotomy	20
Spinocerebellar ataxia 27B: a frequent and slowly progressive autosomal-dominant cerebellar ataxia—experience from an Italian cohort	20
Retinal thickness as a biomarker of cognitive impairment in manifest Huntington’s disease	20
Systematic assessment of square-wave jerks in progressive supranuclear palsy: a video-oculographic study	20
Dopamine transporter single photon emission computed tomography (DaT-SPECT) use in the diagnosis and clinical management of parkinsonism: an 8-year retrospective study	20
Exploring the impact of 40 Hz multi-luminaire light exposure in Alzheimer's dementia: insights from a convenient sampling, non-randomized case–control study	20
Locus coeruleus degeneration and cerebellar gray matter changes in essential tremor	20
Overcoming traps and pitfalls leading to misinterpretation of normal EEG variants and variation of the background activity	20
Diaschisis: a mechanism for subcortical aphasia?	20
Correlation between cognitive changes and neuroradiological changes over time in multiple sclerosis: a systematic review and meta-analysis	19
The impact of spontaneous intracranial hypotension on social life and health-related quality of life	19
Ocular phenotype and electroretinogram abnormalities in Lafora disease and correlation with disease stage	19
Fingolimod-associated progressive multifocal leukoencephalopathy in a multiple sclerosis patient with a good response to filgrastim	19
Association of rare variants in genes of immune regulation with pediatric autoimmune CNS diseases	19
Effectiveness of endovascular treatment for in-hospital stroke vs. community-onset stroke: a propensity score-matched analysis	19
Correction: Opicapone for the treatment of early wearing-off in levodopa-treated Parkinson’s disease: pooled analysis of patient level data from two randomized open-label studies	19
Good vibrations: tactile cueing for freezing of gait in Parkinson’s disease	19
Occurrence of area postrema syndrome during follow-up: phenotype and influence over NMOSD activity in LATAM in real-world settings	19
Visual quality of life in NMOSD and MOGAD: profiles, dynamics and associations with ageing and vision	19
Burden of disease in myasthenia gravis: taking the patient’s perspective	19
How to identify insular epilepsy	19
Effectiveness and safety of pharmacological prophylaxis for chronic migraine: a systematic review and network meta-analysis	19
Subjective and objective responses to caloric stimulation help separate vestibular migraine from other vestibular disorders	19
Sleep-disordered breathing-related symptoms and risk of stroke: cohort study and Mendelian randomization analysis	18
Correction to: Outcomes of mechanical thrombectomy in patients with acute ischemic stroke and thrombocytopenia: systematic review and meta-analysis	18
Motor function in multiple sclerosis assessed by navigated transcranial magnetic stimulation mapping	18
Optic neuritis and MOGAD	18
Isolated REM sleep behaviour disorder: current diagnostic procedures and emerging new technologies	18
Incidence of cerebral small vessel disease-related MR markers in the Swedish general population ‘Good Aging in Skåne’(GÅS) study	18
Emerging technologies for management of patients with amyotrophic lateral sclerosis: from telehealth to assistive robotics and neural interfaces	18
A disproportionality analysis of surgical site infections across multiple sclerosis disease modifying therapies	18
Louis Jacobsohn-Lask (1863–1940)	18
Leg stereotypy syndrome: phenomenological and quantitative analysis	18
Comparing caloric and self-experienced dizziness symptoms: diagnostic value and implications in functional dizziness	18
Effects of motor–cognitive training on dual-task performance in people with Parkinson’s disease: a systematic review and meta-analysis	18
Correction to: Off-label-dosing of non-vitamin K-dependent oral antagonists in AF patients before and after stroke: results of the prospective multicenter Berlin Atrial Fibrillation Registry	18
Upper motor neuron-predominant motor neuron disease: a novel immunotherapy-responsive association of GAD65 autoimmunity	18
(William) Ritchie Russell (1903–1980)	18
The impact of an MSU service on acute stroke care in a middle-sized city: a simulation-based analysis	18
Late-onset cerebellar ataxia in three European patients with repeat expansions in RFC1 and FGF14: a case series	18
CSF phospho-tau levels at Parkinson’s disease onset predict the risk for development of motor complications	18
Brain positron emission tomography (PET) and cognitive abnormalities one year after COVID-19	18
Clinical and imaging spectrum of non-congenital dominant ACTN2 myopathy	17
Conjugate torsional pendular nystagmus and palatal tremor after unilateral internuclear ophthalmoplegia	17
Explaining cognitive function in multiple sclerosis through networks of grey and white matter features: a joint independent component analysis	17
A nationwide epidemiological study of myasthenia gravis in Turkey	17
Referral trajectories in patients with vertigo, dizziness and balance disorders and their impact on health-related quality of life and functioning: results from the longitudinal multicenter study Mobi	17
Differentiating anti-IgLON5 disease and Lewy body dementia: a systematic review	17
Acetyl-dl-leucine in cerebellar ataxia ([18F]-FDG-PET study): how does a cerebellar disorder influence cortical sensorimotor networks?	17
Resurrection of sildenafil: potential for Huntington’s Disease, too?	17
Comprehensive pathological and genetic investigation of three young adult myotonic dystrophy type 1 patients with sudden unexpected death	17
Pathological findings in autoimmune encephalitis autopsy specimens from cases of suspected prion disease	17
The effect and safety of levodopa alone versus levodopa sparing therapy for early Parkinson’s disease: a systematic review and meta-analysis	17
Clonidine for the management of crises in stiff-person syndrome	17
Chronic vertigo and central oculomotor dysfunction with evidence of anti-ITPR1 antibodies	17
Elevated serum concentrations of GFAP in hereditary transthyretin amyloidosis since pre-symptomatic stages	17
COVID-19 infection after SARS-CoV-2 mRNA vaccination in Multiple Sclerosis, AQP4-antibody NMOSD and MOGAD patients during the Omicron subvariant BA.1/2 wave in Singapore	17
Radiologically isolated syndromes: to treat or not to treat?	17
Time course of lesion-induced atrophy in multiple sclerosis	17
A score to predict the stroke recurrence of patients with embolic stroke of undetermined source	17
Frataxin analysis using triple quadrupole mass spectrometry: application to a large heterogeneous clinical cohort	17
Cognition in cerebellar disorders: What’s in the profile? A systematic review and meta-analysis	17
Risk and sex-specific trends of dementia and stroke in Italy Compared to European and high-income countries and the world: global implications	17
A novel phenotype in an Italian family with a rare progranulin mutation	17
The impact of metformin use on the outcomes of relapse-remitting multiple sclerosis patients receiving interferon beta 1a: an exploratory prospective phase II open-label randomized controlled trial	16
The phenotypic spectrum of epilepsy associated with periventricular nodular heterotopia	16
Incidence, prevalence and disability associated with neurological disorders in Italy between 1990 and 2019: an analysis based on the Global Burden of Disease Study 2019	16
Stroke in adults with primary intracranial tumours	16
Combined central and peripheral demyelination after COVID-19 vaccination	16
Difference in safety and humoral response to mRNA SARS-CoV-2 vaccines in patients with autoimmune neurological disorders: the ANCOVAX study	16
Early therapy initiation is crucial in chronic inflammatory demyelinating polyneuropathy: prospective multimodal data from the German INHIBIT registry	16
Volumetric changes and clinical trajectories in Parkinson’s disease: a prospective multicentric study	16
Sleep characteristics and risk of Alzheimer’s disease: a systematic review and meta-analysis of longitudinal studies	16
Eye movement abnormalities in normal pressure hydrocephalus: a video-oculographic study	16